Skip to main content
. 2014 Feb 18;4(2):e004289. doi: 10.1136/bmjopen-2013-004289

FigureĀ 2.

FigureĀ 2

Kaplan-Meier estimate of new active substance survival: significant therapeutic advance versus no significant therapeutic advance.